Tritonpoint Wealth LLC Has $7.39 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Tritonpoint Wealth LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 14,115 shares of the healthcare conglomerate’s stock after selling 215 shares during the period. Tritonpoint Wealth LLC’s holdings in UnitedHealth Group were worth $7,393,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently made changes to their positions in the company. Financial Management Professionals Inc. increased its stake in UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock worth $1,165,000 after acquiring an additional 17 shares during the period. Richwood Investment Advisors LLC increased its stake in shares of UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock valued at $2,654,000 after purchasing an additional 20 shares during the last quarter. Global Wealth Strategies & Associates boosted its holdings in shares of UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after acquiring an additional 20 shares in the last quarter. 44 Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock valued at $662,000 after acquiring an additional 21 shares in the last quarter. Finally, Prentice Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate’s stock valued at $1,278,000 after acquiring an additional 21 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, CEO Stephen J. Hemsley bought 86,700 shares of the company’s stock in a transaction dated Friday, May 16th. The stock was bought at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

UNH has been the topic of several recent research reports. Truist Financial reaffirmed a “buy” rating and set a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price for the company. in a research report on Monday, May 19th. Raymond James lowered UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Bank of America lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, Wall Street Zen lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $426.52.

UnitedHealth Group Trading Down 1.6%

UnitedHealth Group stock opened at $313.39 on Friday. The stock has a market cap of $284.28 billion, a P/E ratio of 20.22, a PEG ratio of 1.37 and a beta of 0.45. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The firm’s fifty day moving average price is $386.66 and its 200-day moving average price is $474.19. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the company earned $6.91 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.82%. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.